Analytical Data
-
基因名
IL-36 alpha
-
简介
IL-36 α/IL-1F6 protein binds to IL1RL2/IL-36R receptor, activates NF-kappa-B and MAPK pathways, and induces pro-inflammatory responses. IL-36 α/IL-1F6 also upregulates CD83, CD86, and HLA-DR in dendritic cells, promotes dendritic cell maturation, and drives T cell proliferation. Animal-Free IL-36 alpha/IL-1F6 Protein, Human (His) is the recombinant human-derived animal-FreeIL-36 alpha/IL-1F6 protein, expressed by E. coli , with C-His labeled tag. This product is for cell culture use only.
- Application
-
别名
IL-36 alpha; IL-36α; Interleukin-36 Alpha; FIL1 Epsilon; Interleukin-1 Epsilon; IL-1 Epsilon; Interleukin-1 Family Member 6; IL-1F6; IL36A; FIL1E; IL1E; IL1F6
-
种属
Human
-
表达系统
E. coli
-
标签
C-6*His
-
纯度
> 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UHA7
-
表达区间
K6-F158
-
蛋白长度
Full Length of Mature Protein
-
分子量
17 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IL-36 alpha, a member of the IL-1 cytokine family, has gained significant attention in recent years due to its pivotal role in immune responses and its association with various inflammatory conditions, particularly skin diseases such as psoriasis and atopic dermatitis. The protein is mainly produced by epithelial cells and plays a crucial part in the activation of innate immunity by promoting the expression of pro-inflammatory cytokines and chemokines. Researchers have been investigating the therapeutic potential of recombinant IL-36 alpha protein, aiming to understand its mechanisms of action in modulating immune responses. Studies have highlighted its ability to drive the activation and expansion of T helper 17 (Th17) cells, which are instrumental in chronic inflammation. Additionally, there is growing interest in the development of IL-36 alpha as a biomarker for inflammatory diseases, as its expression levels correlate with disease severity. Understanding the structure-function relationship of IL-36 alpha through recombinant protein studies can facilitate the development of targeted therapies, potentially leading to novel treatment strategies for patients suffering from IL-36 alpha-mediated diseases. Overall, the exploration of IL-36 alpha as a therapeutic target represents a promising avenue in the quest for innovative approaches to manage inflammatory disorders.
